PPT-Training in monitoring and epidemiological assessment of mass drug administration for

Author : faustina-dinatale | Published Date : 2019-02-15

Module 1 Background Learning objectives By the end of this module you should be able to answer the questions What is lymphatic filariasis LF What is the Global

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Training in monitoring and epidemiologic..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Training in monitoring and epidemiological assessment of mass drug administration for: Transcript


Module 1 Background Learning objectives By the end of this module you should be able to answer the questions What is lymphatic filariasis LF What is the Global Programme to Eliminate Lymphatic Filariasis GPELF. Objectives. 2. Understand . what the Eliminating . HAB report is, . and why it is important to complete it. . Understand . how to complete your Eliminating HAB . report. . Understand . how to submit your Eliminating HAB . Module 8 Survey sample builder. Learning objectives. Slide. . 2. By the end of this module, you should understand:. how to use the survey sample builder to:. determine the survey design. select random clusters and children or households. Module 2 Eligibility for a TAS. Learning objectives. By the end of this module, you should understand that the eligibility of an . IU. . for a . TAS is . assessed on the basis of:. epidemiological drug coverage (. Module 1 Background. Learning objectives. By the end of this module, you should . be able to answer the questions:. What is . lymphatic filariasis (LF)?. What is the . Global Programme to Eliminate Lymphatic Filariasis (GPELF)?. Module 4 Survey design. Learning objectives. By the end of this module, you should . understand how to determine:. a. survey site. the sampling strategy. the sample size. a critical cut-off. Slide. . Findings From Epidemiological Research Epidemiological analyses in the generalpopulation of the United States indicatethat AA is well known among Hispanicsand African-Americans. Moreover, avast major Eliminating the Snares: . Seeking God’s . Glory. Drink deeply, joyfully and often . from . the “WELLS of salvation.” Isaiah . 12:3. Worshipping . Eliminating the Snares: . Declaring God’s Story. Presented by:. Dr.Rania. Magadmi. The aim of this presentation is to highlight the clinicalinteractions between herbal product and prescribeddrugs. . . Mechanism of Drug- Herb interactions. Literature review. Routes of administration. Chapter Topics. Routes of administration. Oral route of administration. Transmucosal. route of administration. Topical route of administration. Inhalation route of administration. - 663 - 5217 Ju ly 2017 AIMSweb MIDE ( Test of Early Literacy - Spanish ) 17 - 18 The following are appropriate and allowable accommodations for MIDE administration during screening/benchmarking . M N-02-01-11 Page 1 of 31SELF-Illinois Department of Human ServicesDivision of Developmental DisabilitiesClient Name SS -- Medicaid ID Provider Name ID DHS Network General Instructions1For all resp The intent is to annually monitor all providers for attendance reconciling enrollment/attendance certifications with sign-in/SCHOOL READINESS PROVIDER MONITORING TOOL determine if the non-compliance OCTOBER 2011. Drug Therapy Monitoring.  . Definition. Drug therapy monitoring, also known as Therapeutic Drug Monitoring (TDM), is a means of monitoring drug levels in the blood.. Purpose. TDM is employed to measure blood drug levels so that the most effective dosage can be determined, with toxicity prevented. TDM is also utilized to identify noncompliant patients (those patients who, for whatever reason, either cannot or will not comply with drug dosages as prescribed by the physician).. Source:. TG-. Cogni. topic driver. Title:. TDD update: TG-. Cogni. (. Neurocognitive disorders. ). Purpose:. Discussion. Contact:. Marc Lecoultre. E-mail: . ml@mllab.ai. Abstract:. This PPT summarized the content of E-010 with the TDD for the .

Download Document

Here is the link to download the presentation.
"Training in monitoring and epidemiological assessment of mass drug administration for"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents